Wary pharma: AstraZeneca sours on UK

In a world of infinite content, who wins and who loses? Our correspondent explains what the proliferation of AI-generated art means for human artists. What the prevalence of male-female friendships tell us about a society. And why you should propose with a yellow-gold ring. Liste ...  عرض المزيد

Each year, The Economist tries to identify which country has improved the most, whether economically, politically or in other ways. In a turbulent year, the choice was tricky. We unveil the result. And The Economist Educational Foundation helps kids worldwide be more news-savvy. ...  عرض المزيد

Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean a ...  عرض المزيد

America’s health secretary, RFK Jr, is known for his opposition to vaccines, particularly mRNA jabs, that have the potential to treat a large swathe of diseases. Slashing funding will have long term implications beyond America. Our correspondent visits Britain’s biggest and newes ...  عرض المزيد

With China as its new rival, America is reviving old wartime facilities across the Pacific. Our correspondent visits an abandoned airfield that has been given new life. The outlook for climate technology is surprisingly bright. And why the universe of Hello Kitty keeps expanding. ...  عرض المزيد

Since Donald Trump announced punishing tariffs on “Liberation Day” last week, stock markets have fallen and governments and businesses scrambled to respond. Our correspondent discusses the impact on the global economy. Do personalised diets really improve gut health (9:16)? And g ...  عرض المزيد